{"nct_id":"NCT01490632","title":"A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis","status":"COMPLETED","status_verified_date":"2019-09","start_date":"2011-12","start_date_type":null,"primary_completion_date":"2012-12","primary_completion_date_type":"ACTUAL","completion_date":"2014-08","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["LLY"]}